The pharmaceutical industry - Prices and progress

被引：75

作者：

Scherer, FM ^{[1
]}

机构：

[1] Harvard Univ, John F Kennedy Sch Govt, Cambridge, MA 02138 USA

来源：

关键词：

D O I：

10.1056/NEJMhpr040117

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：927 / 932

页数：6

共 36 条

[1]

[Anonymous], MEDICARE MEDICAID ST

[2]

[Anonymous], 1977, SALES PROMOTION PROD

[3]

*C BUDG OFF, 1996, MED REB PRESCR DRUGS, P28

[4]

Centers for Medicare and Medicaid Services, NAT HLTH EXP PROJ

[5]

COHEN WM, 2000, 7552 NAT BUR EC RES

[6]

Danzon P., 1997, PHARM PRICE REGULATI

[7]

DANZON PATRICIA M., 1997, PHARM PRICE REGULATI, P15

[8] The price of innovation: new estimates of drug development costs [J].

DiMasi, JA ;

Hansen, RW ;

Grabowski, HG .

[9]

DiMasi JA, 2000, DRUG INF J, V34, P1169, DOI 10.1177/009286150003400425

[10]

*FED TRAD COMMN, 2002, GETT NOT WRIT EFF FI, P1